Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trialThomas Powles, Felipe Reyes, Lajos Géczi et al.|The Lancet Oncology|2021Cited by 645
Somatic mutations of KIT in familial testicular germ cell tumoursElizabeth Rapley, Michael R. Stratton, Sarah L. Hockley et al.|British Journal of Cancer|2004Cited by 96